The Global Surgical
Robots Market by Product Type (Instruments & Accessories, and Robotic
Systems (Da Vinci Surgical, ROSA, MAKO RIO, ROBODOC, and Others)), by Surgery
Type (Gynecology Surgery, General Surgery, Urology Surgery, Cardiovascular
Surgery, Neurosurgery, Orthopedic Surgery, and Other Surgery), and by Region
(North America, Latin America, Europe, Asia Pacific, the Middle East, and
Africa) is estimated US$ 3,380.3 million in 2017 and is projected to exhibit a
CAGR of 13.4% over the forecast period (2017–2025).
The robotic technique are helpful
due to smaller incisions, which lead to lower morbidity, less postoperative
pain, and shorter hospital stays, that is
similar to minimally invasive surgery. According to the data published
in Frontiers in Surgery Journal in 2016, over 3,200 robotic platforms have been
installed worldwide and approximately 570,000 da Vinci procedures were
performed in 2014.
Key players in the surgical
robots market are focused on acquisition and new product launches in order to
enhance their market share. For instance, Stryker acquired Mako Surgical
Robotic Systems for US$ 1.65 Bn in 2013 and in 2016, it launched Mako surgical
robots for total knee replacement. Furthermore, in 2015, TransEnterix acquired
SOFAR Surgical Robotics unit for US$ 100 Mn. In 2016, Zimmer Biomet Holding
Inc. acquired surgical robotics provider, Medtech SA, for US$ 132 Mn to
increase its portfolio and in 2016, MEDTECH received clearance from the U.S.
Food and Drug Administration (FDA) to market the ROSA Spine robot in the U.S.
Furthermore, in 2013, Auris Surgical Robotics acquired Hassen Medical, as the
Hassen Medical specialized in intravascular robotic catheter systems.
* The sample copy includes: Report Summary, Table of
Contents, Segmentation, Competitive Landscape, Report Structure, Methodology.
Request a sample copy
of this report: https://www.coherentmarketinsights.com/insight/request-sample/496
In 2016, the FDA granted 510(k)
clearance to the Ares robot-assisted bronchoscopy platform developed by
stealthy Auris Surgical Robotics In 2015, Smith & Nephew — a British-based
orthopedics giant — expanded its foothold in the surgical robotics market by
acquiring Blue Belt Technologies and its Navio robotics system, which is a
U.S.-based company.
Browse 27 Market Data Tables and
32 Figures spread through 172 Pages and in-depth TOC on Surgical Robots By
Product Type (Instruments & Accessories and Robotic Systems (Da Vinci
Surgical, ROSA, MAKO RIO, ROBODOC and Others)) By Surgery Type (Gynecology
Surgery, General Surgery, Urology Surgery, Cardiovascular Surgery,
Neurosurgery, Orthopedic Surgery and Other Surgery) and By Region (North
America, Latin America, Europe, Asia Pacific, the Middle East, and Africa) -
Global Forecast to 2025.
Increasing US Food and Drug
Administration approval for surgical robots is also expected to favor growth of
surgical robots market. For instance, in October 2017, US Food and Drug
Administration (FDA) approved the Senhance system, of TransEnterix, which is a
robotically assisted surgical device for minimally invasive surgeries. In 2016,
U.S. FDA approved the first medical robot from Auris Surgical — a startup led
by the co-founder of Intuitive Surgical — a developer of Da Vinci robots.
Furthermore, Stryker received FDA approval in August 2015, however, delayed its
worldwide sales until 2017, and so MAKO RIO was used only in 65 hospitals in
the U.S., the U.K., Australia, and Germany from 2015 –2017. In 2014, ROBODOC
Encore Surgical System received 510(k) clearance from the US Food and Drug
Administration (FDA) for total hip Arthroplasty procedures.
Browse Research
Report: https://www.coherentmarketinsights.com/market-insight/surgical-robots-market-496
Key takeaways of the market:
The global surgical robots market
is expected to exhibit a CAGR of 13.4% over the forecast period (2017–2025),
with increasing adoption of surgical robots for minimally invasive surgeries.
For instance, in 2016, approximately 753,000 surgical procedures were performed
with the da Vinci Surgical System, an increase of approximately 15% compared
with approximately 652,000 procedures performed in 2015
Among surgery type segment,
gynecology surgery segment is expected to exhibit a significant CAGR of 28.8%.
This is owing to new product launches for application in gynecological
surgeries. For instance, in October 2017, the FDA approved TransEnterix’s
Senhance robotic system. Moreover, established da Vinci robotic system has also
contributed to growth of the gynecology surgery segment.
The global surgical robots market
is characterized by market expansion in Asia Pacific, North America, and
Europe, which is expected to generate higher market revenue due to increasing
number of acquisitions.
Some major players operating in
the global surgical robots market includes Intutitive Surgical, Think Surgical,
TransEnterix, Zimmer Biomet, Stryker Corporation, Smith & Nephew, and
Medrobotics Corporation.
Buy-Now this research
report: https://www.coherentmarketinsights.com/insight/buy-now/496
About
Coherent Market Insights:
Coherent
Market Insights is a prominent market research and consulting firm offering
action-ready syndicated research reports, custom market analysis, consulting services,
and competitive analysis through various recommendations related to emerging
market trends, technologies, and potential absolute dollar opportunity.
Contact
Us:
mailto:sales@coherentmarketinsights.com
U.S.
Office:
Name: Mr. Shah
Coherent
Market Insights 1001 4th Ave,
# 3200
Seattle, WA 98154, U.S.
US : +1-206-701-6702
UK : +44-020-8133-4027
JAPAN : +050-5539-1737
No comments:
Post a Comment